Options to purchase securities

Nephrocare Health Services' board approved the Employee Stock Option Scheme 2026, enabling the grant of up to 2,006,814 options, representing approximately 2% of its paid-up equity share capital, subject to shareholder and regulatory approvals. Concurrently, the company approved providing collateral/security support of up to INR 70 Crore to its overseas step-down wholly-owned subsidiary in Saudi Arabia. This support aims to enable the subsidiary to avail credit facilities, reflecting a revised funding and operating structure for its Saudi operations and facilitating international growth.